The FDA has granted approval for Lipfendra, the first oral PCSK9 inhibitor designed to treat high cholesterol, particularly familial hypercholesterolemia. This new medication offers a non-invasive option for patients and is intended to be used alongside dietary changes and exerc…
The FDA has approved Lipfendra (enlicitide), marking the first oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor for adults with high cholesterol. This approval…
The FDA has approved Lipfendra (enlicitide), the first oral therapy to inhibit PCSK9, aimed at reducing low-density lipoprotein cholesterol (LDL-C) in adults with high cholesterol…
The FDA has granted priority review to Lipfendra, the first oral medication designed to block the PCSK9 protein, which is crucial in regulating LDL cholesterol levels. This develo…
Recent viral claims suggest that statins, commonly prescribed cholesterol-lowering medications, may contribute to dementia. However, scientific evidence reviewed by DW Fact Check…
The FDA has approved Lipfendra, a groundbreaking pill from Merck designed to significantly lower cholesterol levels in patients at high risk of heart disease. This noninjectable m…
The FDA has approved Lipfendra, the first once-daily oral PCSK9 inhibitor, which can reduce LDL cholesterol levels by 56% to 60% when used alongside statins. Developed by Merck, t…
A recent study published in the Journal of Clinical Lipidology suggests that incorporating one avocado into the daily diet may help reduce low-density lipoprotein (LDL) cholestero…
The National Institutes of Health's 'All of Us' Research Program has emerged as the world's largest repository of integrated health and genomic data, aiming to collect information…
A recent article from Health.com explores the potential benefits of high-protein breakfasts for lowering cholesterol, highlighting foods like eggs, oatmeal, nuts, and Greek yogurt…
A recent systematic review and meta-analysis of 50 randomized controlled trials involving 1,780 adults with overweight or obesity has found that regular exercise significantly inc…
Recent reports highlight how after-dinner habits can affect cholesterol levels and overall heart health. Factors such as evening physical activity, sleep quality, and food choices…
Scribe Therapeutics experienced a significant surge in its stock price, climbing approximately 67% on its first day of trading on the Nasdaq after raising $128.7 million in its in…